Zenith Health Care
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Zenith Healthcare Limited's board approved a scheme to amalgamate Achyut Healthcare Limited into itself, creating a combined pharmaceutical entity with a significantly enlarged balance sheet. Achyut Healthcare, with a net worth of ₹35.06 crore and assets of ₹38.09 crore, is substantially larger than Zenith, which has a net worth of ₹7.42 crore. Under the share swap, shareholders of Achyut will receive 119 equity shares of Zenith for every 50 shares held, resulting in the issuance of over 57 crore new Zenith shares. The amalgamation, subject to NCLT and shareholder approvals, will boost promoter holding in the listed entity to 45.8% from 28.74% and is expected to streamline operations, enhance manufacturing capabilities, and provide access to regulated export markets.
Powered by Tijori
Zenith Healthcare Limited's board approved a scheme to amalgamate Achyut Healthcare Limited into itself, creating a combined pharmaceutical entity with a significantly enlarged balance sheet. Achyut Healthcare, with a net worth of ₹35.06 crore and assets of ₹38.09 crore, is substantially larger than Zenith, which has a net worth of ₹7.42 crore. Under the share swap, shareholders of Achyut will receive 119 equity shares of Zenith for every 50 shares held, resulting in the issuance of over 57 crore new Zenith shares. The amalgamation, subject to NCLT and shareholder approvals, will boost promoter holding in the listed entity to 45.8% from 28.74% and is expected to streamline operations, enhance manufacturing capabilities, and provide access to regulated export markets.
Powered by Tijori
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Zenith Health Care do?
Zenith Health Care Ltd specializes in the manufacturing of tablets, capsules, ointments, and liquid injectables, among other medical products.
Who are the competitors of Zenith Health Care?
Zenith Health Care major competitors are Kobo Biotech, Rekvina Laboratories, Omkar Pharmachem, Norris Medicines, Desh Rakshak Aushdh, Emmessar Biotech&Nut, Colinz Laboratories. Market Cap of Zenith Health Care is ₹17 Crs. While the median market cap of its peers are ₹15 Crs.
Is Zenith Health Care financially stable compared to its competitors?
Zenith Health Care seems to be less financially stable compared to its competitors. Altman Z score of Zenith Health Care is 4.28 and is ranked 4 out of its 8 competitors.
Does Zenith Health Care pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Zenith Health Care latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Zenith Health Care allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Zenith Health Care balance sheet?
Balance sheet of Zenith Health Care is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Zenith Health Care improving?
No, profit is decreasing. The profit of Zenith Health Care is ₹0.01 Crs for Mar 2026, ₹0.07 Crs for Mar 2025 and ₹0.2 Crs for Mar 2024
Is the debt of Zenith Health Care increasing or decreasing?
Yes, The net debt of Zenith Health Care is increasing. Latest net debt of Zenith Health Care is -₹0.73 Crs as of Mar-26. This is greater than Mar-25 when it was -₹4.79 Crs.
Is Zenith Health Care stock expensive?
Zenith Health Care is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Zenith Health Care is 3417, while 3 year average PE is 309. Also latest EV/EBITDA of Zenith Health Care is 0.0 while 3yr average is 78.57.
Has the share price of Zenith Health Care grown faster than its competition?
Zenith Health Care has given better returns compared to its competitors. Zenith Health Care has grown at ~12.49% over the last 8yrs while peers have grown at a median rate of 3.58%
Is the promoter bullish about Zenith Health Care?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Zenith Health Care is 28.74% and last quarter promoter holding is 28.74%.
Are mutual funds buying/selling Zenith Health Care?
The mutual fund holding of Zenith Health Care is stable. The current mutual fund holding in Zenith Health Care is 0.39% while previous quarter holding is 0.39%.